Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Bravamax vs Vigil (Modafinil) in Healthy Volunteers
NCT05855187Phase 1Completed
- Sponsor
- Genuine Research Center
- Start
- Nov 2022
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of modafinil in narcolepsy (2 arms), sponsored by Genuine Research Center. Primary endpoints: Maximum Plasma Concentration, Area Under the Curve to the last measurable time point and 1 more. Started Nov 2022; status: completed.
02
Drugs
modafinil
03
Conditions
narcolepsy
Beyond the preview
Go deeper on NCT05855187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05855187.